查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446504

定序市場規模、佔有率和趨勢分析報告：按產品/服務、應用、工作流程、最終用途、區域和細分市場進行預測，2024-2030 年

Sequencing Market Size, Share & Trends Analysis Report By Product & Services (Platform, Software), By Application (Oncology, Clinical Investigation), By Workflow, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

定序市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球定序市場規模將達到624.8億美元，2024年至2030年複合年成長率為22.2%。

政府和私人組織對基因組研究和開發的投資增加，以及對個人化醫療和精準治療的需求不斷成長，預計將導致這些技術的採用增加，進一步提振市場。例如，2022年12月，英國政府宣布將與國家醫療服務體系（NHS）合作投資2.2236億美元用於基因組研究。該投資旨在探索利用全基因組定序治療和發現新生兒罕見遺傳疾病的有效性。

曲狀桿菌感染疾病、甲型肝炎、B型肝炎、C型肝炎、愛滋病毒、流感和腦膜炎球菌病菌感染等感染疾病發病率的上升是市場的主要促進因素。據世界衛生組織稱，到 2022 年，將有 3900 萬人感染愛滋病毒。據乙型肝炎基金會稱，每年約有 150 萬人新感染B型肝炎。隨著疫情和傳染病的增加，對準確、快速定序技術的需求不斷成長，以幫助識別導致這些疾病的病原體。技術的進步使得對病原體基因組序列測定變得更加容易和快捷，使醫療保健提供者和研究人員能夠更好地了解這些疾病的傳播並開發有針對性的治療方法和疫苗。我現在可以做到。因此，由於預防感染疾病和改善全球健康的需要，預計該市場將繼續成長。

COVID-19大流行對市場產生了重大影響。病毒的快速傳播增加了對這些技術的需求，以便更好地了解病毒並追蹤其突變。這導致對測序設備、試劑和服務的需求激增。然而，這種流行病也對市場成長產生了負面影響，因為它擾亂了供應鏈並導致研究計劃延遲。

該市場面臨一些挑戰，包括與定序和資料分析相關的高成本、這些技術的準確性和可靠性的限制，以及管理和解釋定序產生的大量資料的困難。此外，人們也擔心與基因資訊定序相關的資料隱私和倫理影響。仍需要標準化和控制定序品管，提高研究人員和臨床醫生的可及性，並使其更便宜。

定序市場報告亮點

  • 消耗品在產品和服務領域佔據主導地位，到 2023 年，其佔有率將超過 44.5%，因為研究和診斷領域不斷成長的定序需求正在推動新型和改進消耗品的開發。
  • 從應用領域來看，2023年腫瘤學佔最大市場佔有率。同時，總體基因體學、流行病學和藥物開發預計將以最快的複合年成長率成長。
  • 到 2023 年，定序預計將在工作流程領域佔據主導地位，資料分析將以最快的複合年成長率成長。
  • 在推進知識和為科學利益做出貢獻的願望的推動下，學術研究帶來了更多的創新研究，在 2023 年獲得最大佔有率並主導最終用途領域。
  • 北美以49.4%的市佔率主導定序市場。這是由於高感染疾病負擔、高購買力平價、政府對優質醫療保健的支持、可報銷等因素所造成的。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • SWOT 分析；按因素（政治/法律、經濟/技術）
    • 波特五力分析
    • COVID-19感染疾病的影響分析

第4章定序市場：產品與服務的業務分析

  • 定序市場：產品和服務的市場佔有率分析
  • 按產品和服務
  • 平台
  • 消耗品
  • 服務
  • 軟體

第5章定序市場：應用業務分析

  • 定序市場：應用市場佔有率分析
  • 按用途
  • 腫瘤學
  • 臨床調查
  • 生殖健康
  • HLA型檢測/免疫系統監測
  • 總體基因體學、流行病學、藥物發現
  • 農業基因組學與法醫學
  • 消費者基因體學

第6章定序市場：工作流程業務分析

  • 定序市場：工作流程市場佔有率分析
  • 按工作流程
  • 前序
  • 順序
  • 資料分析

第7章定序市場：最終用途業務分析

  • 定序市場：最終用途市場佔有率分析
  • 按最終用途
  • 學術研究
  • 臨床調查
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他用戶

第8章定序市場：區域業務分析

  • 2023 年及 2030 年按地區定序市場佔有率
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第9章 競爭形勢

  • 財務績效
  • 參與企業
    • 市場領導者
  • 參與企業概況
    • Illumina, Inc.
    • F. Hoffman-La Roche Ltd.
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • Oxford Nanopore Technologies
    • PierianDx
    • Genomatix GmbH
    • DNASTAR, Inc.
    • Perkin Elmer, Inc.
    • Eurofins GATC Biotech GmbH
    • BGI
  • 策略規劃
    • 擴張
    • 獲得
    • 合作
    • 產品/服務發布
    • 合夥
    • 其他
Product Code: GVR-4-68040-195-0

Sequencing Market Growth & Trends:

The global sequencing market size is anticipated to reach USD 62.48 billion by 2030, growing at a CAGR of 22.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing investments by governments and private organizations in genomic research and development and the increasing demand for personalized medicine and precision treatments have led to a rise in the adoption of these technologies, which are expected to boost the market further. For instance, in December 2022, the UK government announced a USD 222.36 million investment in genomics research in partnership with the National Health Service (NHS). This investment aimed to explore the effectiveness of using whole-genome sequencing to treat and find rare genetic diseases in newborn babies.

The rising number of infectious diseases such as Campylobacter infection, Hepatitis A, B, C, HIV, Influenza (Flu), and Meningococcal disease has been a major driver of the market. According to WHO, in 2022, 39 million people are living with HIV. As per the Hepatitis B Foundation, approximately 1.5 million people are newly infected due to hepatitis B each year. As the number of outbreaks and epidemics increases, there is a growing demand for accurate and rapid sequencing technologies that can help identify the pathogens responsible for these diseases. With the advancement of technologies, it has become easier and faster to sequence the genomes of pathogens, enabling healthcare providers and researchers to understand the spread of these diseases better and develop targeted treatments and vaccines. As a result, the market is expected to continue to grow in the coming years, driven by the need to combat infectious diseases and improve global health.

The COVID-19 pandemic has had a significant impact on the market. With the rapid spread of the virus, there has been an increased demand for these technologies to understand the virus better and track its mutations. This has led to a surge in demand for sequencing instruments, reagents, and services. However, the pandemic has also disrupted supply chains and caused delays in research projects, which has had a negative impact on the market growth.

The market faces several challenges, including high costs associated with sequencing and data analysis, limited accuracy and reliability of these technologies, and difficulties in managing and interpreting large amounts of data generated by sequencing. In addition, there are concerns regarding data privacy and ethical implications related to sequencing genetic information. There is still a need for standardization and quality control in sequencing, improved accessibility, and affordability for researchers and clinicians.

Sequencing Market Report Highlights:

  • Consumables dominated the product & service segment with more than 44.5% share in 2023 owing to the increasing demand for sequencing in research and diagnostics, which has resulted in the development of new and improved consumables
  • In application segment, oncology held the largest market share in 2023. On the other hand, metagenomics, epidemiology & drug development is expected to grow at the fastest CAGR
  • In 2023, sequencing dominated the workflow segment, and data analysis is expected to at the fastest CAGR
  • Academic research dominated the end-use segment with largest share in 2023 driven by a desire to advance knowledge and contribute to scientific interests, resulting in more innovative research
  • North America dominated the sequencing market with a share of 49.4% owing to factors such as the significant burden of infectious diseases, high purchasing power parity, government support for quality healthcare, and availability of reimbursement

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Services
    • 1.2.2. Application
    • 1.2.3. Workflow
    • 1.2.4. End-use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Increasing Cases of Cancer
      • 3.3.1.2. Technological advances in next-generation sequencing technologies
      • 3.3.1.3. High investment in research and development
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Lack of Skilled Professionals
      • 3.3.2.2. Legal and Ethical Issues
  • 3.4. Industry Analysis Tools
    • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.4.2. Porter's Five Forces Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Sequencing market: Product & Services Business Analysis

  • 4.1. Sequencing market: Product & Services Market Share Analysis
  • 4.2. Sequencing market Estimates & Forecast, By Product & Services (USD Million)
  • 4.3. Platform
    • 4.3.1. Global Platform Market, 2018 - 2030 (USD Million)
    • 4.3.2. 1st Generation of Sequencing Device
      • 4.3.2.1. Global 1st Generation of Sequencing Device Market, 2018 - 2030 (USD Million)
    • 4.3.3. 2nd Generation of Sequencing Device
      • 4.3.3.1. Global 2nd Generation of Sequencing Device Market, 2018 - 2030 (USD Million)
    • 4.3.4. 3rd Generation of Sequencing Device
      • 4.3.4.1. Global 3rd Generation of Sequencing Device Market, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 4.4.2. Kits
      • 4.4.2.1. Global Kits Market, 2018 - 2030 (USD Million)
      • 4.4.2.2. DNA Library Preparation
      • 4.4.2.2.1. Global DNA Library Preparation Market, 2018 - 2030 (USD Million)
      • 4.4.2.3. RNA Library Preparation
      • 4.4.2.3.1. Global RNA Library Preparation Market, 2018 - 2030 (USD Million)
      • 4.4.2.4. Target enrichment
      • 4.4.2.4.1. Global Target enrichment Market, 2018 - 2030 (USD Million)
      • 4.4.2.5. Library quantification
      • 4.4.2.5.1. Global Library quantification Market, 2018 - 2030 (USD Million)
      • 4.4.2.6. Purification & quality control
      • 4.4.2.6.1. Global Purification & quality control Market, 2018 - 2030 (USD Million)
      • 4.4.2.7. Others
      • 4.4.2.7.1. Global Others Market, 2018 - 2030 (USD Million)
    • 4.4.3. Reagents
      • 4.4.3.1. Global Reagents Market, 2018 - 2030 (USD Million)
      • 4.4.3.2. Sample Prep
      • 4.4.3.2.1. Global Sample Prep Market, 2018 - 2030 (USD Million)
      • 4.4.3.3. Library preparation and amplification
      • 4.4.3.3.1. Global Library preparation and amplification Market, 2018 - 2030 (USD Million)
      • 4.4.3.4. Sequencing
      • 4.4.3.4.1. Global Sequencing Market, 2018 - 2030 (USD Million)
    • 4.4.4. Accessories
      • 4.4.4.1. Global Accessories Market, 2018 - 2030 (USD Million)
      • 4.4.4.2. Collection tubes
      • 4.4.4.2.1. Global Collection tubes Market, 2018 - 2030 (USD Million)
      • 4.4.4.3. Plates
      • 4.4.4.3.1. Global Plates Market, 2018 - 2030 (USD Million)
      • 4.4.4.4. Others
      • 4.4.4.4.1. Global Others Market, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Global Services Market, 2018 - 2030 (USD Million)
  • 4.6. Software
    • 4.6.1. Global Software Market, 2018 - 2030 (USD Million)

Chapter 5. Sequencing Market: Application Business Analysis

  • 5.1. Sequencing Market: Application Market Share Analysis
  • 5.2. Sequencing Market Estimates & Forecast, By Application (USD Million)
  • 5.3. Oncology
    • 5.3.1. Global Oncology Market, 2018 - 2030 (USD Million)
    • 5.3.2. Diagnostics and Screening
      • 5.3.2.1. Global Diagnostics and Screening Market, 2018 - 2030 (USD Million)
    • 5.3.3. Oncology Screening
      • 5.3.3.1. Global Oncology Screening Market, 2018 - 2030 (USD Million)
      • 5.3.3.1.1. Sporadic Cancer
      • 5.3.3.1.1.1. Global Sporadic Cancer Market, 2018 - 2030 (USD Million)
      • 5.3.3.1.2. Inherited Cancer
      • 5.3.3.1.2.1. Global Inherited Cancer Market, 2018 - 2030 (USD Million)
    • 5.3.4. Companion Diagnostics
      • 5.3.4.1. Global Companion Diagnostics Market, 2018 - 2030 (USD Million)
    • 5.3.5. Other Diagnostics
      • 5.3.5.1. Global Other Diagnostics Market, 2018 - 2030 (USD Million)
    • 5.3.6. Research Studies
      • 5.3.6.1. Global Research Studies Market, 2018 - 2030 (USD Million)
  • 5.4. Clinical Investigation
    • 5.4.1. Global Clinical Investigation Market, 2018 - 2030 (USD Million)
    • 5.4.2. Infectious Diseases
      • 5.4.2.1. Global Infectious Diseases Market, 2018 - 2030 (USD Million)
    • 5.4.3. Inherited Diseases
      • 5.4.3.1. Global Inherited Diseases Market, 2018 - 2030 (USD Million)
    • 5.4.4. Idiopathic Diseases
      • 5.4.4.1. Global Idiopathic Diseases Market, 2018 - 2030 (USD Million)
    • 5.4.5. Non-Communicable/Other Diseases
      • 5.4.5.1. Global Non-Communicable/Other Diseases Market, 2018 - 2030 (USD Million)
  • 5.5. Reproductive Health
    • 5.5.1. Global Reproductive Health Market, 2018 - 2030 (USD Million)
    • 5.5.2. NIPT
      • 5.5.2.1. Global NIPT Market, 2018 - 2030 (USD Million)
      • 5.5.2.2. Aneuploidy
      • 5.5.2.2.1. Global Aneuploidy Market, 2018 - 2030 (USD Million)
      • 5.5.2.3. Microdeletions
      • 5.5.2.3.1. Global Microdeletions Market, 2018 - 2030 (USD Million)
    • 5.5.3. PGT
      • 5.5.3.1. Global PGT Market, 2018 - 2030 (USD Million)
    • 5.5.4. Newborn Genetic Screening
      • 5.5.4.1. Global Newborn Genetic Screening Market, 2018 - 2030 (USD Million)
    • 5.5.5. Single Gene Analysis
      • 5.5.5.1. Global Single Gene Analysis Market, 2018 - 2030 (USD Million)
  • 5.6. HLA Typing/Immune System Monitoring
    • 5.6.1. Global HLA Typing/Immune System Monitoring Market, 2018 - 2030 (USD Million)
  • 5.7. Metagenomics, Epidemiology & Drug Development
    • 5.7.1. Global Metagenomics, Epidemiology & Drug Development Market, 2018 - 2030 (USD Million)
  • 5.8. Agrigenomics & Forensics
    • 5.8.1. Global Agrigenomics & Forensics Market, 2018 - 2030 (USD Million)
  • 5.9. Consumer Genomics
    • 5.9.1. Global Consumer Genomics Market, 2018 - 2030 (USD Million)

Chapter 6. Sequencing Market: Workflow Business Analysis

  • 6.1. Sequencing Market: Workflow Market Share Analysis
  • 6.2. Sequencing Market Estimates & Forecast, By Workflow (USD Million)
  • 6.3. Pre-Sequencing
    • 6.3.1. Global Pre-sequencing Market, 2018 - 2030 (USD Million)
  • 6.4. Sequencing
    • 6.4.1. Global Sequencing Market, 2018 - 2030 (USD Million)
  • 6.5. Data Analysis
    • 6.5.1. Global Data Analysis Market, 2018 - 2030 (USD Million)

Chapter 7. Sequencing Market: End-use Business Analysis

  • 7.1. Sequencing market: End-use Market Share Analysis
  • 7.2. Sequencing market Estimates & Forecast, By End-use (USD Million)
  • 7.3. Academic Research
    • 7.3.1. Global Academic Research Market, 2018 - 2030 (USD Million)
  • 7.4. Clinical Research
    • 7.4.1. Global Clinical Research Market, 2018 - 2030 (USD Million)
  • 7.5. Hospitals & Clinics
    • 7.5.1. Global Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 7.6. Pharma & Biotech Entities
    • 7.6.1. Global Pharma & Biotech Entities Market, 2018 - 2030 (USD Million)
  • 7.7. Other Users
    • 7.7.1. Global Other Users Market, 2018 - 2030 (USD Million)

Chapter 8. Sequencing Market: Regional Business Analysis

  • 8.1. Sequencing Market Share, By Region, 2023 & 2030
  • 8.2. North America
    • 8.2.1. North America Sequencing market, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Competitive Scenario
      • 8.2.2.3. Target Disease Prevalence
      • 8.2.2.4. Regulatory Framework
      • 8.2.2.5. U.S. Sequencing market, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Competitive Scenario
      • 8.2.3.3. Target Disease Prevalence
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Canada Sequencing market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Sequencing market, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Target Disease Prevalence
      • 8.3.2.4. Regulatory Framework
      • 8.3.2.5. UK Sequencing market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Target Disease Prevalence
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Germany Sequencing market, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Target Disease Prevalence
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. France Sequencing market, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Competitive Scenario
      • 8.3.5.3. Target Disease Prevalence
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Italy Sequencing market, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Competitive Scenario
      • 8.3.6.3. Target Disease Prevalence
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Spain Sequencing market, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Competitive Scenario
      • 8.3.7.3. Target Disease Prevalence
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Denmark Sequencing market, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Competitive Scenario
      • 8.3.8.3. Target Disease Prevalence
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Sweden Sequencing market, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Competitive Scenario
      • 8.3.9.3. Target Disease Prevalence
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Norway Sequencing market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Sequencing market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Target Disease Prevalence
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Japan Sequencing market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Target Disease Prevalence
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. China Sequencing market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Target Disease Prevalence
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. India Sequencing market, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Target Disease Prevalence
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Australia Sequencing market, 2018 - 2030 (USD Million)
    • 8.4.6. Thailand
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Target Disease Prevalence
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Thailand Sequencing market, 2018 - 2030 (USD Million)
    • 8.4.7. South Korea
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Target Disease Prevalence
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. South Korea Sequencing market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Sequencing market, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Target Disease Prevalence
      • 8.5.2.4. Regulatory Framework
      • 8.5.2.5. Brazil Sequencing market, 2018 - 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Target Disease Prevalence
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Mexico Sequencing market, 2018 - 2030 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Target Disease Prevalence
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Argentina Sequencing market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA Sequencing market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Target Disease Prevalence
      • 8.6.2.4. Regulatory Framework
      • 8.6.2.5. South Africa Sequencing market, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Target Disease Prevalence
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Saudi Arabia Sequencing market, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Target Disease Prevalence
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. UAE Sequencing market, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Target Disease Prevalence
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Kuwait Sequencing market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Financial Performance
  • 9.2. Participant Categorization
    • 9.2.1. Market Leaders
      • 9.2.1.1. Market share analysis, 2023
  • 9.3. Participant's Overview
    • 9.3.1. Illumina, Inc.
      • 9.3.1.1. Overview
      • 9.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.1.3. Technology Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. F. Hoffman-La Roche Ltd.
      • 9.3.2.1. Overview
      • 9.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.2.3. Technology Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. QIAGEN
      • 9.3.3.1. Overview
      • 9.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.3.3. Technology Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Thermo Fisher Scientific, Inc.
      • 9.3.4.1. Overview
      • 9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.4.3. Technology Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Bio-Rad Laboratories, Inc.
      • 9.3.5.1. Overview
      • 9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.5.3. Technology Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Oxford Nanopore Technologies
      • 9.3.6.1. Overview
      • 9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.6.3. Technology Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. PierianDx
      • 9.3.7.1. Overview
      • 9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.7.3. Technology Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Genomatix GmbH
      • 9.3.8.1. Overview
      • 9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.8.3. Technology Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. DNASTAR, Inc.
      • 9.3.9.1. Overview
      • 9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.9.3. Technology Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Perkin Elmer, Inc.
      • 9.3.10.1. Overview
      • 9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.10.3. Technology Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Eurofins GATC Biotech GmbH
      • 9.3.11.1. Overview
      • 9.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.11.3. Technology Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. BGI
      • 9.3.12.1. Overview
      • 9.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.12.3. Technology Benchmarking
      • 9.3.12.4. Strategic Initiatives
  • 9.4. Strategy Mapping
    • 9.4.1. Expansion
    • 9.4.2. Acquisition
    • 9.4.3. Collaborations
    • 9.4.4. Product/service launch
    • 9.4.5. Partnerships
    • 9.4.6. Others

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 4 Global sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 Global sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Global sequencing market, by region, 2018 - 2030 (USD Million)
  • Table 8 North America sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 10 North America sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 12 North America sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 U.S. sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 14 U.S. sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 16 U.S. sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Canada sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 18 Canada sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 20 Canada sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Europe sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 22 Europe sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 23 Europe sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 24 Europe sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 25 Europe sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 UK sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 27 UK sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 29 UK sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Germany sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 31 Germany sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 32 Germany sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 33 Germany sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 France sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 35 France sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 36 France sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 37 France sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Italy sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 39 Italy sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 40 Italy sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 41 Italy sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Spain sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 43 Spain sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 44 Spain sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 45 Spain sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Denmark sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 47 Denmark sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 48 Denmark sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 49 Denmark sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Sweden sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 51 Sweden sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 52 Sweden sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 53 Sweden sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Norway sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 55 Norway sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 56 Norway sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 57 Norway sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Japan sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 64 Japan sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 65 Japan sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 66 Japan sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 China sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 68 China sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 69 China sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 70 China sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 India sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 72 India sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 73 India sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 74 India sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Australia sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 76 Australia sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 77 Australia sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 78 Australia sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Thailand sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 80 Thailand sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 81 Thailand sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 82 Thailand sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 South Korea sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 84 South Korea sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Korea sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 86 South Korea sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 Latin America sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 88 Latin America sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 89 Latin America sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 90 Latin America sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 91 Latin America sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Brazil sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 93 Brazil sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 94 Brazil sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 95 Brazil sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 Mexico sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 97 Mexico sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 98 Mexico sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 99 Mexico sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 100 Argentina sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 101 Argentina sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 103 Argentina sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 109 South Africa sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 110 South Africa sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 112 South Africa sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 117 UAE sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 118 UAE sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 120 UAE sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 122 Kuwait sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 124 Kuwait sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 125 Participant's overview
  • Table 126 Financial performance
  • Table 127 Key companies undergoing expansions
  • Table 128 Key companies undergoing acquisitions
  • Table 129 Key companies undergoing collaborations
  • Table 130 Key companies launching new products/services
  • Table 131 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Sequencing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market outlook
  • Fig. 13 Related/ancillary market outlook
  • Fig. 14 Genomics - Industry value chain analysis
  • Fig. 15 Sequencing market driver analysis
  • Fig. 16 Sequencing market restraint analysis
  • Fig. 17 Sequencing market: Porter's analysis
  • Fig. 18 Sequencing market: Product & services outlook and key takeaways
  • Fig. 19 Sequencing market: Product & services market share analysis, 2023-2030
  • Fig. 20 Global sequencing by Platform market, 2018 - 2030 (USD Million)
  • Fig. 21 Global sequencing by 1st Generation of sequencing device market, 2018 - 2030 (USD Million)
  • Fig. 22 Global sequencing by 2nd Generation of sequencing device market, 2018 - 2030 (USD Million)
  • Fig. 23 Global sequencing by 3rd Generation of sequencing device market, 2018 - 2030 (USD Million)
  • Fig. 24 Global sequencing by Consumables market, 2018 - 2030 (USD Million)
  • Fig. 25 Global sequencing by Kits market, 2018 - 2030 (USD Million)
  • Fig. 26 Global sequencing by DNA Library Preparation market, 2018 - 2030 (USD Million)
  • Fig. 27 Global sequencing by RNA Library Preparation market, 2018 - 2030 (USD Million)
  • Fig. 28 Global sequencing by Target enrichment market, 2018 - 2030 (USD Million)
  • Fig. 29 Global sequencing by Library quantification market, 2018 - 2030 (USD Million)
  • Fig. 30 Global sequencing by Purification & quality control market, 2018 - 2030 (USD Million)
  • Fig. 31 Global sequencing by Others market, 2018 - 2030 (USD Million)
  • Fig. 32 Global sequencing by Reagents market, 2018 - 2030 (USD Million)
  • Fig. 33 Global sequencing by Sample Prep market, 2018 - 2030 (USD Million)
  • Fig. 34 Global sequencing by Library preparation and amplification market, 2018 - 2030 (USD Million)
  • Fig. 35 Global sequencing by Sequencing market, 2018 - 2030 (USD Million)
  • Fig. 36 Global sequencing by Accessories market, 2018 - 2030 (USD Million)
  • Fig. 37 Global sequencing by Collection tubes market, 2018 - 2030 (USD Million)
  • Fig. 38 Global sequencing by Plates market, 2018 - 2030 (USD Million)
  • Fig. 39 Global sequencing by Others market, 2018 - 2030 (USD Million)
  • Fig. 40 Global sequencing by Services market, 2018 - 2030 (USD Million)
  • Fig. 41 Global sequencing by Software market, 2018 - 2030 (USD Million)
  • Fig. 42 Sequencing market: Application outlook and key takeaways
  • Fig. 43 Sequencing market: Application market share analysis, 2023-2030
  • Fig. 44 Global sequencing by Oncology market, 2018 - 2030 (USD Million)
  • Fig. 45 Global sequencing by Diagnostics and Screening market, 2018 - 2030 (USD Million)
  • Fig. 46 Global sequencing by Oncology Screening market, 2018 - 2030 (USD Million)
  • Fig. 47 Global sequencing by Sporadic Cancer market, 2018 - 2030 (USD Million)
  • Fig. 48 Global sequencing by Inherited Cancer market, 2018 - 2030 (USD Million)
  • Fig. 49 Global sequencing by Companion Diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 50 Global sequencing by Other Diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 51 Global sequencing by Research Studies market, 2018 - 2030 (USD Million)
  • Fig. 52 Global sequencing by Clinical Investigation market, 2018 - 2030 (USD Million)
  • Fig. 53 Global sequencing by Infectious Diseases market, 2018 - 2030 (USD Million)
  • Fig. 54 Global sequencing by Inherited Diseases market, 2018 - 2030 (USD Million)
  • Fig. 55 Global sequencing by Idiopathic Diseases market, 2018 - 2030 (USD Million)
  • Fig. 56 Global sequencing by Non-Communicable/Other Diseases market, 2018 - 2030 (USD Million)
  • Fig. 57 Global sequencing by Reproductive Health market, 2018 - 2030 (USD Million)
  • Fig. 58 Global sequencing by NIPT market, 2018 - 2030 (USD Million)
  • Fig. 59 Global sequencing by Aneuploidy market, 2018 - 2030 (USD Million)
  • Fig. 60 Global sequencing by Microdeletions market, 2018 - 2030 (USD Million)
  • Fig. 61 Global sequencing by PGT market, 2018 - 2030 (USD Million)
  • Fig. 62 Global sequencing by Newborn Genetic Screening market, 2018 - 2030 (USD Million)
  • Fig. 63 Global sequencing by Single Gene Analysis market, 2018 - 2030 (USD Million)
  • Fig. 64 Global sequencing by HLA Typing/Immune System Monitoring market, 2018 - 2030 (USD Million)
  • Fig. 65 Global sequencing by Metagenomics, Epidemiology & Drug Development market, 2018 - 2030 (USD Million)
  • Fig. 66 Global sequencing by Agrigenomics & Forensics market, 2018 - 2030 (USD Million)
  • Fig. 67 Global sequencing by Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 68 Sequencing market: Workflow outlook and key takeaways
  • Fig. 69 Sequencing market: Workflow market share analysis, 2023-2030
  • Fig. 70 Global sequencing by Pre-Sequencing market, 2018 - 2030 (USD Million)
  • Fig. 71 Global sequencing by Sequencing market, 2018 - 2030 (USD Million)
  • Fig. 72 Global sequencing by Data Analysis market, 2018 - 2030 (USD Million)
  • Fig. 73 Sequencing market: End-use outlook and key takeaways
  • Fig. 74 Sequencing market: End-use market share analysis, 2023-2030
  • Fig. 75 Global sequencing by Academic Research market, 2018 - 2030 (USD Million)
  • Fig. 76 Global sequencing by Clinical Research market, 2018 - 2030 (USD Million)
  • Fig. 77 Global sequencing by Hospitals & Clinics market, 2018 - 2030 (USD Million)
  • Fig. 78 Global sequencing by Pharma & Biotech Entities market, 2018 - 2030 (USD Million)
  • Fig. 79 Global sequencing by Other users market, 2018 - 2030 (USD Million)
  • Fig. 80 Regional marketplace: Key takeaways
  • Fig. 81 Regional marketplace: Key takeaways
  • Fig. 82 North America sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 U.S. key country dynamics
  • Fig. 84 U.S. sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Canada key country dynamics
  • Fig. 86 Canada sequencing market, 2018 - 2030 (USD Million)
  • Fig. 87 Europe sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 UK key country dynamics
  • Fig. 89 UK sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Germany key country dynamics
  • Fig. 91 Germany sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 France key country dynamics
  • Fig. 93 France sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Italy key country dynamics
  • Fig. 95 Italy sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Spain key country dynamics
  • Fig. 97 Spain sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Denmark key country dynamics
  • Fig. 99 Denmark sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Sweden key country dynamics
  • Fig. 101 Sweden sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Norway key country dynamics
  • Fig. 103 Norway sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 Asia-Pacific sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 Japan key country dynamics
  • Fig. 106 Japan sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 China key country dynamics
  • Fig. 108 China sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 109 India key country dynamics
  • Fig. 110 India sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 111 Australia key country dynamics
  • Fig. 112 Australia sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 113 Thailand key country dynamics
  • Fig. 114 Thailand sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 115 South Korea key country dynamics
  • Fig. 116 South Korea sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 117 Latin America sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 118 Brazil key country dynamics
  • Fig. 119 Brazil sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 120 Mexico key country dynamics
  • Fig. 121 Mexico sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 122 Argentina key country dynamics
  • Fig. 123 Argentina sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 124 MEA sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 125 South Africa key country dynamics
  • Fig. 126 South Africa sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 127 Saudi Arabia key country dynamics
  • Fig. 128 Saudi Arabia sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 129 UAE key country dynamics
  • Fig. 130 UAE sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 131 Kuwait key country dynamics
  • Fig. 132 Kuwait sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 133 Key company categorization
  • Fig. 134 Company market positioning
  • Fig. 135 Market participant categorization
  • Fig. 136 Strategy framework